Journal profile · ALLERGY
Alergologia Polska-Polish Journal of Allergology
ISSN 2353-3854 · eISSN 2391-6052
Alergologia Polska-Polish Journal of Allergology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.1 (journal website); diamond open access (no APC); no APC; 36 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Alergologia Polska-Polish Journal of Allergology is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Allergic Rhinitis and Sensitization, Asthma and respiratory diseases and Urticaria and Related Conditions, together about 46.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Editorial Board of Alergologia Polska – Polish Journal of Allergology takes under consideration for publication original articles with the understanding that neither the manuscript nor any part of its essential substance, tables or figures have been published previously in print form or electronically and are not under consideration by any other publication or electronic medium. Copies of any closely related manuscripts should be submitted to the Editor along with the manuscript that is to be considered by Alergologia Polska – Polish Journal of Allergology. Each submission packet should include the statement signed by the first author that the work has not been published previously or submitted elsewhere for review and a copyright transfer.
From the journal's Aims & Scope
Research area (LetPub): ALLERGY
Editorial board by country: none in mainland China; most named Poland 22, United Kingdom 5, United States 2, Ukraine 2, Germany 1 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Allergic Rhinitis and SensitizationMedicine20.9%
- Asthma and respiratory diseasesMedicine15.9%
- Urticaria and Related ConditionsMedicine9.6%
- Food Allergy and Anaphylaxis ResearchMedicine9%
- Drug-Induced Adverse ReactionsMedicine5.1%
- Dermatology and Skin DiseasesMedicine4.7%
- Contact Dermatitis and AllergiesMedicine3.5%
- Respiratory and Cough-Related ResearchMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ScopusPubMedPublisher website
Other: CrossRef
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.1Publisher website ·
- h-index
- 9OpenAlex ·
- i10-index
- 8OpenAlex ·
- 2-year mean citedness
- 0.94OpenAlex ·
- Self-citation rate
- 36.4%LetPub ·
- Share of gold OA articles
- 99.22%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 486 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 39 | 3 |
| 2025 | 36 | 36 | 46 |
| 2024 | 59 | 59 | 77 |
| 2023 | 40 | 40 | 103 |
| 2022 | 33 | 33 | 42 |
| 2021 | 24 | 24 | 26 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- Vancouver
- Suggested reviewers
- Optional
Article types accepted6
- case report• Case report (not longer than 8 pages)Length not stated
- editorial• Editorial (not longer than 3 pages)Length not stated
- letter to editor• Letter to editor (not longer than 1 page)Length not stated
- original research article• Original research article (not more than 10 pages)Length not stated
- reviewManuscripts are evaluated on the basis that they present new insights to the investigated topic, are likely to contribute to a research progress. It is understo…Length not stated
- review article• Review article (not more than 8 pages)Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Peer review, Trial registration / reporting guidelines
- Authorship Changes to authorship
Language: American or British English accepted, not a mixture. Model summary
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
Conflict of interest disclosure required for all authors. Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in Journal P…
Source ↗Publisher website ·- License & copyright Copyright
Copyright transfer via Journal Publishing Agreement; CC BY-NC-SA 4.0 license. Model summary
The Authors of the article are asked to complete a ‘Journal Publishing Agreement’.
Source ↗Publisher website ·- Peer review Review process
Double blind peer review; minimum two independent expert reviewers. Model summary
Manuscripts are evaluated on the basis that they present new insights to the investigated topic, are likely to contribute to a research progress. It is understood that all authors listed on a manuscript have agreed to its submission. The signature of the corresponding author on the letter of submission signifies that these conditions have been fulfilled. Received manuscripts are first examined by …
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trial registration required per ICMJE. Model summary
The ICMJE requires - and recommends that all medical journal editors require - registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for article publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2353-3854
- Electronic ISSN
- 2391-6052
- Society / sponsor
- Polish Society of Allergology
- Latest issue on the website
- Volume 13 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Alergologia Polska-Polish Journal of Allergology
What CAS zone is Alergologia Polska-Polish Journal of Allergology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Alergologia Polska-Polish Journal of Allergology is in Zone 4 of Medicine, and in Zone 4 of the minor category Allergy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Alergologia Polska-Polish Journal of Allergology?
The journal's website gives an impact factor of 1.1; this is the journal's own figure, as LetPub lists none for it; h-index 9.
What are the manuscript requirements of Alergologia Polska-Polish Journal of Allergology?
According to the journal's author guidelines: Reference style: Vancouver; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Alergologia Polska-Polish Journal of Allergology based?
Of the 38 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (22), United Kingdom (5) and United States (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Alergologia Polska-Polish Journal of Allergology?
According to LetPub and DOAJ records, Alergologia Polska-Polish Journal of Allergology is indexed in ESCI and DOAJ. The journal's website also lists Scopus and PubMed; that list has not been checked against each database.
Is Alergologia Polska-Polish Journal of Allergology open access, and what is the APC?
Alergologia Polska-Polish Journal of Allergology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .